The Director General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, leaves a press conference organized by the United Nations Correspondents Association in Geneva (ACANU) amid the COVID-19 outbreak, caused by the new coronavirus, at WHO headquarters in Geneva, Switzerland, on July 3. 2020. Fabrice Coffrini / Pool via REUTERS
Coronavirus Vaccine Tracker LIVE Updates: The United States may have four Covid-19 candidate vaccines in large-scale clinical trials by mid-September, according to a report from the United States today. Deputy Chief of Health and Human Services Staff Paul Mango, who is also the agency’s liaison with Operation Warp Speed, said the US government was very pleased with the progress. He added that the agency felt it was “absolutely on track,” in terms of its overall goal, which was tens of millions of (doses of) safe and effective vaccines approved by the end of the calendar year.
- News18.com
- Last update: August 29, 2020 9:52 am IST
- FOLLOW US:
Coronavirus Vaccine Tracker LIVE Updates: Richer countries that join the World Health Organization’s COVID-19 vaccine plan are offered a new option to choose which vaccines to receive while reserving the right to receive their “full share” of doses, according to show documents seen by Reuters. The change appears to be aimed at convincing governments that have negotiated their own bilateral agreements to secure experimental vaccines to also sign up for COVAX’s global facility before Monday’s deadline to submit expressions of interest.
“They are trying to be more flexible for countries to finance themselves to make it more interesting … There are some advantages to incentivize you to pay upfront,” said a Western diplomat familiar with the terms. The United States, Japan, Britain and the European Union have reached their own agreements to secure millions of doses of COVID-19 vaccine for their citizens, ignoring WHO warnings that “vaccine nationalism” will reduce supplies.
Here are the LIVE updates on the coronavirus vaccine:
• US May Approve Covid-19 Vaccine by End of 2020 | The United States may have four Covid-19 candidate vaccines in large-scale clinical trials by mid-September, according to a report from the United States today. Deputy Chief of Health and Human Services Staff Paul Mango, who is also the agency’s liaison with Operation Warp Speed, said the US government was very pleased with the progress. He added that the agency felt it was “absolutely on track”, if not slightly ahead, in terms of its overall goal, which was tens of millions of (doses of) safe and effective vaccines approved by the end of the calendar year. Mango said that each Phase 3 clinical trial would enroll 30,000 volunteers and that the two currently underway are halfway there.
• Sanofi relies more on its coronavirus vaccines | Sanofi’s confidence in its coronavirus vaccine candidates has increased this summer as the French drugmaker prepares to begin clinical trials, its chief executive told Reuters. The company is working on two of the more than 150 potential vaccines that are being developed around the world to deal with the COVID-19 pandemic, which has claimed more than 831,000 lives and caused economic chaos. One candidate, to build on an existing platform that develops vaccines to treat influenza, will use an adjuvant made by Britain’s GlaxoSmithKline (GSK) to increase its efficacy.
• Bangladesh’s Beximco Invests in Serum Institute of India | Bangladesh’s Beximco Pharmaceuticals is investing in the Serum Institute of India (SII) to ensure that Dhaka gets priority access to COVID-19 vaccines being developed by the Indian drug maker, the company said on Friday. The deal announced by Bangladesh’s generic drugmaker comes after Dhaka said this month that it was ready to test candidate vaccines being developed by India as both countries seek to curb the spread of the virus.
• Britain will review the law and allow the use of emergency vaccines | Britain is preparing to revise its laws to allow the emergency use of any effective coronavirus vaccine before it is fully licensed, but only if the vaccines meet required safety and quality standards. In a statement on Friday, Prime Minister Boris Johnson’s Conservative government said it was adopting “strengthened safeguards” to allow the country’s drug regulatory agency to grant a temporary authorization of a COVID-19 vaccine, provided it meets the standards of safety and quality. coronavirus vaccines to receive an emergency approval to immunize people while completing the full licensing process. Vaccines are typically only used after the license review has been completed, a process that can take several months.
• Peru will begin testing the Chinese Sinopharm vaccine | Peru will begin testing coronavirus vaccines from China Sinopharm and US pharmacist Johnson & Johnson in September, the researchers said, which should help the country gain faster access to vaccines once the vaccines are approved.
Sinopharm this week began recruiting up to 6,000 volunteers in Peru, which according to Reuters data has the highest number of deaths from COVID-19 relative to the size of its population. A team of Chinese scientists is expected to arrive in the Andean nation next week to work with local researchers, said Germán Málaga, a physician and principal vaccine researcher at the Cayetano Heredia University in Lima. “This will happen around September 3, to start. Vaccinations on September 8,” he said. Sinopharm clinical trials in Peru are being carried out with Cayetano Heredia and the state-run Universidad Mayor de San Marcos.
• China Approves Use of Emergency Vaccine | Sinovac Biotech’s coronavirus vaccine candidate, CoronaVac, was approved in July for emergency use as part of a program in China to vaccinate high-risk groups such as medical personnel, a person familiar with the matter said. China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), also said it had obtained emergency use approval for a coronavirus vaccine candidate on the social media platform WeChat on Sunday. . CNBG, which has two candidate vaccines in phase 3 clinical trials, did not say which of its vaccines had been licensed for emergency use.
• Donald Trump vows to ‘crush the pandemic’ with a vaccine by the end of the year | In a rallying cry against the pandemic, US President Donald Trump vowed Thursday to “crush” Covid-19 with a vaccine before the end of the year, as he accepted the Republican nomination for a second term as POTUS. The US president said the country has a skilled scientist to develop the coronavirus vaccines in the framework of ‘Operation Warp Speed’.
“We are bringing together America’s scientific genius to produce a vaccine in record time. We will have a safe and effective vaccine this year and together we will squash the virus,” Trump said, adding that three coronavirus vaccines will be ready for production soon. and could be available this year.
Matrix (
[videos] => Matrix ()
[query] => Https://pubstack.nw18.com/pubsync/v1/api/videos/recommended?source=n18english&channels=5d95e6c378c2f2492e2148a2,5d95e6c278c2f2492e214884,5d96f74de3f5f312274ca307&categories=5d95e6d7340a9e4981b2e10a&query=BCG+vaccine%2Ccorona+cases+in+delhi%2Ccorona+vaccine+ in + hindi% 2Ccorona + vaccine + latest + news +% 2Ccorona + vaccines + updates & publish_min = 2020-08-26T07: 58: 51.000Z & publish_max = 2020-08-29T07: 58: 51.000Z & sort_by = date-relevance & order_by = 0 & limit = 2)
.
